HYDROGEL ENTRANT DANS UNE THERAPIE D'ANEVRISMES

European patent · EP1100541 · Deleted

Register entry

Publication number
EP1100541
Application number
EP99918935
Kind
European patent with effect for Switzerland and Liechtenstein
Status
Deleted
Specification
Granted
Filed
Apr 29, 1999
Published
May 23, 2001
Granted
Oct 19, 2005
Deleted
Apr 30, 2018
Reason
Annual fee unpaid
IPC classes
A61K 47/30 (2006.01)
A61K 47/32 (2006.01)
A61K 47/34 (2006.01)
A61K 47/36 (2006.01)
A61K 47/38 (2006.01)
A61K 38/18 (2006.01)
A61K 38/20 (2006.01)
A61K 39/395 (2006.01)
A61K 33/24 (2006.01)
A61K 47/02 (2006.01)
Priority
US 71250 01.05.1998
PCT application
PCT/US1999/009492 29.04.1999
PCT publication
WO1999/056783 11.11.1999
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Nov 21, 2018

    Deleted, fee unpaid

    Published in Swissreg on 21.11.2018

  2. Dec 28, 2007

    Address changed

    Owner
    Micrus Corporation, 495 Clyde Avenue, Mountain View,, California 94043, USA → Micrus Endovascular Corporation, 821 Fox Lane, San Jose, CA 95131, USA

    Published in +pat+ No 24 in 2007

  3. Feb 15, 2006

    Agent entered

    Representative
    Kirker & Cie SA, 122, rue de Genève, Case postale 65, 1226 Thônex (Genève)

    Published in +pat+ No 3 in 2006

  4. Oct 31, 2005

    Granted

    Published in +pat+ No 20 in 2005

Parties

Inventor

DERBIN, J., Todd

Palo Alto, CA 94301, US

KEN, Christopher, G., M.

San Mateo, CA 94403, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.